Search

everythinglearnresearchcommunity

for

Search:↓

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Older skin has higher cancer risk due to inflammation and stem cell issues.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Hair follicles can help diagnose traumatic brain injury quickly and non-invasively.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Balancing testosterone may reduce COVID-19 severity.

Nail changes are common in alopecia areata and can indicate its severity.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Notch1 helps skin heal by attracting cells that aid repair.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

A mutation in the IL2RA gene increases the risk of alopecia areata.

RNase L suppresses regeneration in mammals.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.